Elizabeth S. Warren

Representative Experience

• BioScrip and Option Care Complete Merger to Form Option Care Health

  We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.

   

  We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc.,...
  Read More
  Client Type: Public Company
• American Physician Partners Acquires Emergigroup Physician Associates

  Represented American Physician Partners in its acquisition of Texas-based Emergigroup Physician Associates

  We represented American Physician Partners (APP) in its acquisition of Houston-based Emergigroup Physician Associates, PA (EGPA). EGPA provides emergency medicine...
  Read More
  Client Type: Private Company
• American Physician Partners Acquires Arizona Progressive Medical Associates, PLLC

  Represented American Physician Partners in its acquisition Arizona Progressive Medical Associates

  We represented American Physician Partners (APP) in its acquisition of Arizona Progressive Medical Associates, PLLC based in Mesa, Arizona. This...
  Read More
  Client Type: Private Company
• Quest Diagnostics Acquires ReproSource

  Represented Quest Diagnostics in its acquisition of ReproSource

  We represented Quest Diagnostics (NYSE: DGX) in its acquisition of ReproSource, a Massachusetts-based provider of specialty fertility diagnostic services. Terms...
  Read More
  Client Type: Public Company
• New Mountain Capital-Backed MSD Sold to McKesson

  Represented Medical Specialties Distributors (MSD) to McKesson Corporation.

  We served as co-counsel with Simpson Thatcher & Bartlett LLP in the sale of Medical Specialties Distributors (MSD) to McKesson...
  Read More
  Client Type: Private Company
• AAC Completes Acquisition of AdCare, Inc.

  Represented AAC Holdings, Inc., parent company of American Addiction Centers, in its acquisition of AdCare, Inc.

  Attorneys at Bass, Berry & Sims represented AAC Holdings, Inc. (NYSE: AAC), parent company of American Addiction Centers, in its...
  Read More
  Client Type: Public Company
• Ardent Health Services and The University of Texas System Partner, Form UT Health East Texas

  Served as lead healthcare regulatory counsel to Ardent Health Services in its acquisition of East Texas Medical Center Regional Healthcare System (ETMC)

  We served as lead healthcare regulatory counsel to Ardent Health Services in its acquisition of East Texas Medical Center Regional...
  Read More
  Client Type: Private Company
• Altaris Capital Partners Acquire AGS Health

  Served as an investment firm’s regulatory counsel in its acquisition of a RCM provider

  We served as healthcare regulatory counsel for Altaris Capital Partners in its acquisition of AGS Health. Altaris is an investment...
  Read More
• AAC Holdings Acquires AdCare

  Represented AAC in its definitive agreement to acquire a New England-based addiction treatment provider

  We represented AAC Holdings, Inc. (NYSE: AAC) – parent company of American Addiction Centers – in its definitive agreement to...
  Read More
  Client Type: Public Company
• $420 Million in Debt Financing for Tivity Health

  Represented Tivity Health in a syndicated loan transaction providing the company with a $100 million revolving credit facility, a $70 million term loan A facility, a $150 million delayed draw term loan facility, and an uncommitted incremental accordion facility of $100 million

  We represented Tivity Health in a syndicated loan transaction providing the company with a $100 million revolving credit facility, a...
  Read More
  Client Type: Public Company